Equity Capital Markets

Company · CIK 1894525

Apimeds Pharmaceuticals US, Inc.

CIK1894525 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressNJ
ListedAPUS (NYSE)
First annual or quarterly report2025-04-15

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-282324
IPOFinal prospectus
 2024-09-252025-05-0911

Filings

12
FiledFilingRegistrationAccession
2025-05-09424B4Final prospectus 333-2823240001213900-25-041193
2025-05-05EFFECTDeclared effective 333-2823249999999995-25-001413
2025-02-11EFFECTDeclared effective 333-2823249999999995-25-000387
2025-02-10S-1/AAmendment 333-2823240001213900-25-011555
2025-02-06S-1/AAmendment 333-2823240001213900-25-010958
2025-01-29S-1/AAmendment 333-2823240001213900-25-007894
2025-01-10S-1/AAmendment 333-2823240001213900-25-002220
2024-12-20S-1/AAmendment 333-2823240001213900-24-110650
2024-12-09S-1/AAmendment 333-2823240001213900-24-106589
2024-11-08S-1/AAmendment 333-2823240001213900-24-095559
2024-09-25S-1Registration filed 333-2823240001213900-24-081766
2024-01-29DRSDraft made public 377-070740001213900-24-007296

All filings of this company · CSV